Aliskiren increased adverse events in patients with diabetes and kidney disease who were receiving ACE inhibitors or ARBs

Parving, H.H., Brenner, B.M. and McMurray, J.J. (2013) Aliskiren increased adverse events in patients with diabetes and kidney disease who were receiving ACE inhibitors or ARBs. Annals of Internal Medicine, 158(6), JC7. (doi:10.7326/0003-4819-158-6-201303190-02007)

Full text not currently available from Enlighten.


Item Type:Articles
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:McMurray, Professor John
Authors: Parving, H.H., Brenner, B.M., and McMurray, J.J.
College/School:College of Medical Veterinary and Life Sciences > Institute of Cardiovascular and Medical Sciences
Journal Name:Annals of Internal Medicine
Publisher:American College of Physicians
ISSN:0003-4819

University Staff: Request a correction | Enlighten Editors: Update this record